TG Therapeutics | TGTX - Stock


TG Therapeutics reported $147.97M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Amgen USD 6.22B 34M Jun/2026
Ardelyx USD 128.02M 110.29M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bayer EUR 12.01B 321M Mar/2026
Biogen USD 2.38B 435.3M Jun/2026
Corcept Therapeutics USD 13.18M 295K Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
J&J USD 15.14B 561M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Novartis USD 6.22B 66M Jun/2026
Novavax USD 10.01M 1.45M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 147.97M 18.94M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026